Los Angeles, CA, United States of America

Jennifer R Dwyer

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer R Dwyer. Retrieved from https://idiyas.com/inventor/jennifer-r-dwyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer R Dwyer

Introduction

Jennifer R Dwyer is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of synthetic oxysterols, particularly through her innovative patent related to the hedgehog pathway. Her work has implications for pharmaceutical applications and treatment methods.

Latest Patents

Jennifer R Dwyer holds a patent for "Oxysterol compounds and the hedgehog pathway." This invention focuses on synthetic oxysterols and describes methods for using these compounds, including treating subjects in need thereof. The patent also includes pharmaceutical compositions and kits designed for implementing the methods of the invention. She has 1 patent to her name.

Career Highlights

Jennifer is affiliated with the University of California, where she continues to advance her research and innovation in the field. Her work is recognized for its potential impact on medical treatments and pharmaceutical development.

Collaborations

Jennifer has collaborated with notable colleagues, including Khanhlinh Nguyen and Farhad Parhami. These partnerships enhance her research and contribute to the advancement of her innovative projects.

Conclusion

Jennifer R Dwyer exemplifies the spirit of innovation in the field of synthetic compounds. Her contributions are paving the way for new treatments and pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…